Trial Profile
Pilot study on the efficacy of golimumab in the induction and maintenance of clinical and endoscopic remission in patients with steroid-dependent ulcerative colitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2018
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 12 Dec 2018 Status changed from recruiting to completed.
- 08 Apr 2015 New trial record